Claims
- 1. A method for preventing or treating pain associated with prostate cancer in a mammal in need thereof, comprising administering to said mammal the compound N-[[2′-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1′-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide or a salt thereof in an amount effective therefor.
- 2. The method of claim 1, wherein said mammal is a human.
- 3. A pharmaceutical composition for the prevention or treatment of pain in a mammal, comprising the compound N-[[2′-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1′-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide or a salt thereof in an amount effective therefore in combination with at least one narcotic and a pharmaceutically acceptable vehicle or diluent.
Parent Case Info
This application claims priority to U.S. Provisional Application Serial No. 60/257,840 filed Dec. 21, 2000, the entirety of which is incorporated herein by reference.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
5612359 |
Murugesan |
Mar 1997 |
A |
6043265 |
Murugesan et al. |
Mar 2000 |
A |
Foreign Referenced Citations (3)
Number |
Date |
Country |
WO 9721445 |
Jun 1997 |
WO |
WO 9956761 |
Nov 1999 |
WO |
WO 0191736 |
Dec 2001 |
WO |
Non-Patent Literature Citations (2)
Entry |
Nelson, J.B. et al., BJU International, vol. 85, Supp. 2, pp. 45-48 (Apr. 2000). |
Davar, G. et al., Neuroreport, vol. 9, No. 10, pp. 2279-2283 (Jul. 13, 1998). |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/257840 |
Dec 2000 |
US |